---
aliases:
- (Willis et al., 2022)
author: Willis, Kelcie D. and Ravyts, Scott G. and Lanoye, Autumn and Loughan, Ashlee
  R.
citekey: willis2022SleepDisturbancePrimary
date_added: '2025-03-23'
doi: 10.1007/s00520-021-06476-3
journal: Supportive Care in Cancer
title: 'Sleep Disturbance in Primary Brain Tumor: Prevalence, Risk Factors, and Patient
  Preferences'
year: '2022'

---
# Sleep Disturbance in Primary Brain Tumor: Prevalence, Risk Factors, and Patient Preferences
- [PDF Link](zotero://open-pdf/library/items/BJJBFSP3)

Citation: [@willis2022SleepDisturbancePrimary]

***
# TL;DR (Summary)
- 61.5% of primary brain tumor (PBT) patients reported poor sleep quality, and 21.5% endorsed symptoms of insomnia.
- Corticosteroid use (OR = 5.97; CI, 1.15, 31.07) and fatigue severity (OR = 1.66; CI, 1.23, 2.25) were significant predictors of insomnia.
- 64% of patients with insomnia felt their symptoms were not well-managed by their medical team.
- First study to use validated questionnaires (ISI and PSQI) exclusively in PBT patients to assess sleep disturbance.
- Unique focus on patients' beliefs about symptom management and treatment preferences.
- Authors suggest increased screening and monitoring of sleep disturbance in neuro-oncology clinics.
- Recommend exploring the efficacy of behavioral treatments like CBT-I for PBT patients.
- High prevalence of sleep disturbance in PBT patients compared to general population.
- Similar interest in pharmacological and behavioral treatments among PBT patients.

# 中文摘要 (TL;DR)
- 61.5% 的原發性腦瘤（PBT）患者報告睡眠質量差，21.5% 的患者確認有失眠症狀。
- 使用皮質類固醇（OR = 5.97; CI, 1.15, 31.07）和疲勞嚴重程度（OR = 1.66; CI, 1.23, 2.25）是失眠的顯著預測因素。
- 64% 的失眠患者認為他們的症狀未被醫療團隊妥善管理。
- 首次研究使用經驗證的問卷（ISI 和 PSQI）專門評估 PBT 患者的睡眠障礙。
- 獨特地關注患者對症狀管理和治療偏好的看法。
- 作者建議在神經腫瘤學診所增加對睡眠障礙的篩查和監測。
- 建議探索針對 PBT 患者的行為治療（如 CBT-I）的療效。
- 與一般人群相比，PBT 患者中睡眠障礙的高發生率。
- PBT 患者對藥物和行為治療的興趣相似。
